Ticker League

EBITDA Margin for Merck & Co. (MRK) 1985-2026

As of · Reported

Metric

TTM

28.6%

YoY change

+3.47pp

Trough year (FY2023)

11.5%

Peak year (FY2009)

66.8%

EBITDA Margin history chart for Merck & Co. (MRK) from 2016 to 2025

Latest: 43.5%

EBITDA Margin change chart for Merck & Co. (MRK) from 2016 to 2025

Latest: +3.47pp

EBITDA Margin history table for Merck & Co. (MRK) from 1985 to 2025

  • FY202543.5%+3.47pp
  • FY202440.1%+28.57pp
  • FY202311.5%-24.47pp
  • FY202236.0%-0.80pp
  • FY202136.8%+12.23pp
  • FY202024.5%-4.55pp
  • FY201929.1%-4.01pp
  • FY201833.1%+3.30pp
  • FY201729.8%+2.60pp
  • FY201627.2%-4.33pp
  • FY201531.5%-26.98pp
  • FY201458.5%+28.21pp
  • FY201330.3%-4.48pp
  • FY201234.8%+2.59pp
  • FY201132.2%+10.97pp
  • FY201021.2%-45.62pp
  • FY200966.8%+17.28pp
  • FY200849.5%+18.10pp
  • FY200731.4%+5.12pp
  • FY200626.3%-8.07pp
  • FY200534.4%-1.36pp
  • FY200435.7%-8.22pp
  • FY200344.0%-4.17pp
  • FY200248.1%-0.99pp
  • FY200149.1%+22.64pp
  • FY200026.5%-1.21pp
  • FY199927.7%+0.21pp
  • FY199827.5%-0.87pp
  • FY199728.3%-1.47pp
  • FY199629.8%-1.74pp
  • FY199531.5%-3.73pp
  • FY199435.3%-5.69pp
  • FY199341.0%+1.50pp
  • FY199239.5%+0.25pp
  • FY199139.2%+1.34pp
  • FY199037.9%+0.35pp
  • FY198937.5%+2.64pp
  • FY198834.9%+3.68pp
  • FY198731.2%+1.29pp
  • FY198629.9%+1.10pp
  • FY198528.8%—

EBITDA Margin values are taken from Merck & Co.'s reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Merck & Co. (MRK)

According to Merck & Co.'s latest reported financial statements, the company's latest reported EBITDA margin is 28.6%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

As of the 2025 fiscal year, Merck & Co. (MRK) reported EBITDA margin of 43.53% – expanded 3.5 percentage points year-over-year.

66.81% stands as the all-time-high annual EBITDA margin, posted in 2009, against a low of 11.49% during 2023.

Merck & Co. EBITDA Margin by Year

Merck & Co. EBITDA Margin 2025: 43.5%

In 2025, Merck & Co. reported EBITDA margin of 43.53%, expanded 3.5 percentage points from 2024.

Merck & Co. EBITDA Margin 2024: 40.1%

Merck & Co. EBITDA margin in 2024 was 40.06%, expanded 28.6 percentage points from 2023.

Merck & Co. EBITDA Margin 2023: 11.5%

2023's EBITDA margin for Merck & Co. came in at 11.49%, contracted 24.5 percentage points from 2022. This figure represents the lowest annual value in the available history.

Merck & Co. EBITDA Margin 2022: 36.0%

Merck & Co. posted EBITDA margin of 35.95% in 2022, contracted 0.8 percentage points from 2021.

Merck & Co. EBITDA Margin 2021: 36.8%

Merck & Co. EBITDA margin in 2021 was 36.75%.

See more financial history for Merck & Co. (MRK).

Sector peers by EBITDA Margin

Healthcare peers of Merck & Co. (MRK), ranked by their latest EBITDA margin

Frequently asked questions

Merck & Co. (MRK) Key Financials

Charts, filings, and peer comparison for every metric

Operations

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview
Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.